ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

154
Analysis
Health CareSouth Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
23 Oct 2020 13:14

Will SK Holdings Required to Sell a 25% Stake in SK Biopharm Due to Changes in the Fair Trade Act?

One of the most important developments arising in Korea is the potential amendment of the Fair Trade Act, which includes taking strict actions...

Logo
449 Views
Share
bullishHYBE
16 Sep 2020 10:53
Logo
483 Views
Share
bullishKakao Games
10 Sep 2020 06:08
Logo
487 Views
Share
bearishDouzone Bizon
09 Sep 2020 08:34
Logo
579 Views
Share
bearishHYBE
08 Sep 2020 10:30

Interest Comparisons of Upcoming Korean Large-Cap IPOs: Kakao Games & Big Hit Entertainment

Based on the Smartkarma's platform interest rates comparison, there is overwhelming evidence that suggests the LACK of interest in the Big Hit...

Logo
381 Views
Share
x